Efficacy and safety of avutometinib ± defactinib in recurrent low grade serous ovarian cancer: primary analysis of ENGOT-OV60/GOG-3052/RAMP 201
Banerjee, S. ; Aghajanian, C. ; Van Nieuwenhuysen, E. ; Santin, A. ; Ring, K. ; Colombo, N. ; Thaker, P. ; Prendergast, E. ; Moore, K. ; Chon, H. S. ... show 10 more
Banerjee, S.
Aghajanian, C.
Van Nieuwenhuysen, E.
Santin, A.
Ring, K.
Colombo, N.
Thaker, P.
Prendergast, E.
Moore, K.
Chon, H. S.
Abstract
Affiliation
Royal Marsden NHS Fdn Trust, London, England
GTG UK, Inst Canc Res, London, England
Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA
Univ Hosp Leuven, Leuven Cance Inst, BGOG, Leuven, Belgium
Yale Univ, Sch Med, Div Gynecol Oncol, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA
Univ Virginia, Dept Obstet & Gynecol, Div Gynecol Oncol, Charlottesville, VA USA
IRCCS, European Inst Oncol, Gynecol Oncol Program, Milan, Italy
Univ Milano Bicocca, Dept Med & Surg, Milan, Italy
Washington Univ St Louis, Sch Med, Div Gynecol Oncol, St Louis, MO USA
Minnesota Oncol, Gynecol Oncol, Minneapolis, MN USA
Univ Oklahoma, Hlth Sci Ctr, Stephenson Oklahoma Canc Ctr, Oklahoma City, OK USA
H Lee Moffitt Canc Ctr & Res Inst, Dept Gynecol Oncol, Tampa, FL USA
Christie NHS Fdn Trust, Med Oncol, Manchester, England
Univ Manchester, GTG UK, Manchester, England
Ohio State Univ, James Comprehens Canc Ctr, Columbus, OH USA
Florida Canc Specialists, W Palm Beach, FL USA
Ramon y Cajal Univ Hosp, Hosp Ramon y Cajal, Ramon y Cajal Hlth Res Inst IRYCIS, Med Oncol Dept,GEICO, Madrid, Spain
ICM Val Aurelle Parc Euromed, Oncol Med, GINECO, Paris, France
CHU Jean Minjoz, Med Oncol Dept, GINECO, Besancon, France
Verastem Oncol, Needham, MA USA
Description
Date
2024
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Banerjee S, Aghajanian C, Van Nieuwenhuysen E, Santin A, Ring K, Colombo N, et al. Efficacy and safety of avutometinib ± defactinib in recurrent low grade serous ovarian cancer: primary analysis of ENGOT-OV60/GOG-3052/RAMP 201. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2024 OCT;34(SUPPL_3):A13-A. PubMed PMID: WOS:001444792200025. English.